Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX62 Ivosidenib
D11090 Ivosidenib (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Ivosidenib
D11090 Ivosidenib (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
IDH1* [HSA_VAR:3417v1]
D11090 Ivosidenib (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11090
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11090
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11090
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D11090